Tear and serum eosinophil cationic protein levels in seasonal allergic conjunctivitis

European Journal of Ophthalmology

Volumn 13, Issue 8, 2003, Pages 671-675

  Acar, N ^a   Toker, Ebru ^a,b   Kazokoglu H ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Inonu Caddesi   (Turkey)

Author keywords

Eosinophil cationic protein; Lodoxamide; Seasonal allergic conjunctivitis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EYE DROPS; LODOXAMIDE;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; LACRIMAL FLUID LEVEL; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEASONAL VARIATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0242428201     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210301300801     Document Type: Article

References (32)

1. Bonini S, Bonini S. IgE and non-IgE mechanisms in ocular allergy. Ann Allergy 1993; 71: 296-9.
2. Bonini S, Bonini S, Bucci MG, et al. Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol 1990; 86: 869-76.
3. Trocme SD, Aldave AJ. The eye and the eosinophil. Surv Ophthalmol 1994; 39: 241-52.
4. Friedlander MH, Okumato M, Kelly MA. Diagnosis of allergic conjunctivitis. Arch Ophthalmol 1984; 102: 1198-9
5. Abelson MB. Conjunctival eosinophils in allergic ocular diseases. Arch Ophthalmol 1983; 101: 555-6.
6. Kari O, Haahtela T. Conjunctival eosinophilia in atopic and non-atopic external eye symptoms. Acta Ophthalmol 1992; 70: 335-40.
7. Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi AG, Plebani M. Tear and serum soluble leucocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129: 151-8.
8. Heilgenhaus A, Schaller J, Mauβ S, et al. Eosinophil granule proteins expressed in ocular cicatrial pemphigoid. Br J Ophthalmol 1998; 82: 312-7.
9. Trocme SD, Hallberg CK, Gill KS, Gleich GJ, Tyring SK, Brysk MM. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci 1997; 38: 593-9.
10. Trocme SD, Glelch GJ, Kephart GM, Zieske JD. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing in vitro. Invest Ophthalmol Vis Sci 1994; 35: 3051-6.
11. Olsson I, Venge P. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 1974; 44: 235-46.
12. Oh JW, Shin JC, Jang SJ, Lee HB. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Ann Allergy Asthma Immunol 1999; 82:579-85.
13. Montan PG, Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996; 80: 556-60.
14. Rasp G, Thomas PA, Bujia J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994; 24: 1151-6.
15. DeMonchy JG, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-6.
16. Bousquet J, Chanez P, Lacoste JY, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991: 88: 649-60.
17. Rak S, Lowhagen O, Venge P, The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988; 82: 470-80.
18. Venge P. Soluble markers of allergic inflammation. Allergy 1994; 49: 1-8.
19. Knani J, Campbell A, Enander I, Peterson CG, Michel FB, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992; 90: 880-9.
20. Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM, Spellman JM. Effect of Iodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol 1993; 101: 102-6.
21. Capron M, Loiseau S, Papin JP, Robertson S, Capron A. Inhibitory effects of Iodoxamide on eosinophil activation. Int Arch Allergy Immunol 1998; 116: 140-6.
22. Ohashi Y, Nakai Y, Kakinoki Y, et al. Effect of immunotherapy on serum levels of eosinophil cationic protein in perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997; 106: 848-53.
23. Tomassini M, Magrini L, Bonini S, Lambiase A, Bonini S. Increased serum levels of eosinophil cationic protein and eosinophil derived neurotoxin (protein X) in vernal keratoconjunctivitis. Ophthalmology 1994; 101: 1808-11.
24. Dahl R, Venge P, Olsson I. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma: studies during inhalation challenge test. Allergy 1978; 33: 211-5.
25. Ferguson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995; 95: 23-8.
26. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992; 47: 450-5.
27. Parronchi P, De Carli M, Manetti R, et al. Aberrant interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects. Eur J Immunol 1992; 22: 1615-20.
28. Trocme SD, Kephart GM, Allansmith MR, Burne WM, Gleich GJ. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 1989; 108: 57-63.
29. Trocme SD, Kephart GM, Bourne WM. Eosinophil major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol 1993; 115: 640-3.
30. Bacon AS, Tuft SJ, Metz DM, et al. The origin of keratopathy in chronic allergic eye disease: a histopathological study. Eye 1993; 7: 529-34.
31. Leonardi A, Borghesan F, Faggian D, Secchi AG, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995; 50: 610-3.
32. Leonardi A, Borghesan F, Averello A, Plebani M, Secchi AG. Effect of Iodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol 1997; 81: 23-6.